These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 18949668)

  • 1. TNFalpha-blocking agents or conventional immunosuppressive drugs in the therapy of children with uveitis? - an evidence based approach.
    Winterhalter S; Niehues T
    Klin Padiatr; 2008; 220(6):342-7. PubMed ID: 18949668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [EBM analysis: classic DMARDs (disease-modifying antirheumatic drugs) and immunosuppressants in arthritis and uveitis].
    Niehues T; Winterhalter S; Zierhut M; Michels H; Becker MD; Heiligenhaus A
    Klin Monbl Augenheilkd; 2007 Jun; 224(6):520-5. PubMed ID: 17594624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on treatment of arthritis in children: new treatments, new goals.
    Lovell DJ
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):72-6. PubMed ID: 17121494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-TNFalpha treatment of juvenile uveitis].
    Fledelius HC; Nielsen SM; Nissen KR; Pedersen FK; Zak MS
    Ugeskr Laeger; 2007 Apr; 169(14):1309-12. PubMed ID: 17437693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFalpha agents.
    Saurenmann RK; Levin AV; Feldman BM; Laxer RM; Schneider R; Silverman ED
    J Pediatr; 2006 Dec; 149(6):833-6. PubMed ID: 17137902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitors of tumour necrosis factor-alpha for the treatment of arthritis and uveitis in childhood].
    Heiligenhaus A; Horneff G; Greiner K; Mackensen F; Zierhut M; Foeldvari I; Michels H
    Klin Monbl Augenheilkd; 2007 Jun; 224(6):526-31. PubMed ID: 17594625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis.
    Foeldvari I; Wierk A
    J Rheumatol; 2005 Feb; 32(2):362-5. PubMed ID: 15693100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis.
    Zulian F; Balzarin M; Falcini F; Martini G; Alessio M; Cimaz R; Cimino L; Zannin ME
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):821-5. PubMed ID: 20191477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current therapeutic approaches to autoimmune chronic uveitis in children.
    Simonini G; Cantarini L; Bresci C; Lorusso M; Galeazzi M; Cimaz R
    Autoimmun Rev; 2010 Aug; 9(10):674-83. PubMed ID: 20553975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of medications used in juvenile rheumatoid arthritis.
    Guthrie B; Rouster-Stevens KA; Reynolds SL
    Pediatr Emerg Care; 2007 Jan; 23(1):38-46. PubMed ID: 17228221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azathioprine as a treatment option for uveitis in patients with juvenile idiopathic arthritis.
    Goebel JC; Roesel M; Heinz C; Michels H; Ganser G; Heiligenhaus A
    Br J Ophthalmol; 2011 Feb; 95(2):209-13. PubMed ID: 20584711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile idiopathic arthritis--current and future therapies.
    Kahn P
    Bull NYU Hosp Jt Dis; 2009; 67(3):291-302. PubMed ID: 19852753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile idiopathic arthritis - an update on pharmacotherapy.
    Kahn P
    Bull NYU Hosp Jt Dis; 2011; 69(3):264-76. PubMed ID: 22035441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Guidelines in RA treatment: concepts on safety and recommendations using anti-TNF-alpha inhibitors. Grupo de Estudio de Nuevas Terapias de Enfermedades reumáticas (GENTE)].
    Díaz-Jouanen E; Abud-Mendoza C; Garza-Elizondo MA; Medrano-Ramírez G; Burgos-Vargas R; Orozco-Alcalá JJ; Pacheco-Tena CF; Pineda C; Pozos-Espíndola JC; Ramos-Niembro F; Robles-San-Román M; Santana-Sahagún JE;
    Rev Invest Clin; 2009; 61(3):252-66. PubMed ID: 19736814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etanercept and uveitis in patients with juvenile idiopathic arthritis.
    Schmeling H; Horneff G
    Rheumatology (Oxford); 2005 Aug; 44(8):1008-11. PubMed ID: 15855187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on biologics in juvenile idiopathic arthritis.
    Ilowite NT
    Curr Opin Rheumatol; 2008 Sep; 20(5):613-8. PubMed ID: 18698187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of tumor necrosis factor inhibitors in uveitis.
    Rabinovich CE
    Curr Opin Rheumatol; 2007 Sep; 19(5):482-6. PubMed ID: 17762615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for the development of cataract requiring surgery in uveitis associated with juvenile idiopathic arthritis.
    Sijssens KM; Rothova A; Van De Vijver DA; Stilma JS; De Boer JH
    Am J Ophthalmol; 2007 Oct; 144(4):574-9. PubMed ID: 17706583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evidence-based use of methotrexate in children with rheumatic disorders. Consensus statement of the Working Group for Children and Adolescents with Rheumatic Diseases in Germany (AGKJR) and the Working Group Pediatric Rheumatology Austria].
    Niehues T; Horneff G; Michels H; Sailer Höck M; Schuchmann L
    Z Rheumatol; 2004 Apr; 63(2):147-58. PubMed ID: 15112095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medical treatment of juvenile idiopathic arthritis].
    Horneff G; Augustin S
    Med Monatsschr Pharm; 2008 Sep; 31(9):326-36; quiz 337-8. PubMed ID: 18831464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.